Arrowhead Pharmaceuticals, Inc.

Ensign Peak Advisors, Inc ARWR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

23,336

Value ($000)

1,549

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	1,549	0.0%	23,336	12/31/2025
2025 Q3	11/13/2025	745	0.0%	21,591	9/30/2025
2025 Q2	8/12/2025	767	0.0%	48,541	6/30/2025
2025 Q1	5/14/2025	618	0.0%	48,541	3/31/2025
2024 Q4	2/14/2025	913	0.0%	48,541	12/31/2024
2024 Q3	11/14/2024	940	0.0%	48,541	9/30/2024
2024 Q2	8/13/2024	1,262	0.0%	48,541	6/30/2024
2024 Q1	5/14/2024	1,388	0.0%	48,541	3/31/2024
2023 Q4	2/14/2024	1,560	0.0%	50,990	12/31/2023
2023 Q3	11/13/2023	1,370	0.0%	50,990	9/30/2023
2023 Q2	8/14/2023	1,818	0.0%	50,990	6/30/2023
2023 Q1	5/15/2023	1,295	0.0%	50,990	3/31/2023
2022 Q4	2/13/2023	7,238	0.0%	178,460	12/31/2022
2022 Q3	11/14/2022	5,288	0.0%	160,010	9/30/2022
2022 Q2	8/12/2022	4,849	0.0%	137,706	6/30/2022
2022 Q1	5/16/2022	1,530	0.0%	33,260	3/31/2022
2021 Q4	2/11/2022	2,283	0.0%	34,435	12/31/2021
2021 Q3	11/12/2021	5,213	0.0%	83,500	9/30/2021
2021 Q2	8/13/2021	8,372	0.0%	101,096	6/30/2021
2021 Q1	5/12/2021	7,060	0.0%	106,466	3/31/2021
2020 Q4	2/12/2021	8,484	0.0%	110,572	12/31/2020
2020 Q3	11/12/2020	5,435	0.0%	126,210	9/30/2020
2020 Q2	8/12/2020	3,870	0.0%	89,610	6/30/2020
2020 Q1	5/11/2020	3,221	0.0%	111,977	3/31/2020
2019 Q4	2/14/2020	6,869	0.0%	108,296	12/31/2019